Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
Annals of Dermatology2016Vol. 28(1), pp. 22–22
Citations Over TimeTop 10% of 2016 papers
Gaewon Nam, Se Kyoo Jeong, Bu Man Park, Sin Hee Lee, Hyun Jong Kim, Seung-Phil Hong, Beom Joon Kim, Bong-Woo Kim
Abstract
Our results indicate that CB1R agonists down-regulate mast cell activation and may be used for relieving inflammatory symptoms mediated by mast cell activation, such as atopic dermatitis, psoriasis, and contact dermatitis.
Related Papers
- → CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents(2004)241 cited
- → Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes(2002)101 cited
- → Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles(1992)141 cited
- → Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor(2006)9 cited
- → Cannabinoid Ligand-Receptor Signaling During Early Pregnancy in the Mouse(1999)3 cited